| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | TESARO INC | 10,275,113 | 863,623,000 | 44.82% | ||
| 2 | GROUPON INC | 33,109,905 | 107,607,000 | 5.59% | ||
| 3 | SENSEONICS HOLDINGS INC | 26,303,189 | 103,372,000 | 5.37% | ||
| 4 | ARDELYX INC COM | 11,792,631 | 102,950,000 | 5.34% | ||
| 5 | DERMIRA INC | 3,506,649 | 102,569,000 | 5.32% | ||
| 6 | ADAPTIMMUNE THERAPEUTICS PLC | 9,880,999 | 80,530,000 | 4.18% | ||
| 7 | EPIZYME INC COM | 6,260,851 | 64,111,000 | 3.33% | ||
| 8 | GLYCOMIMETICS INC | 8,584,128 | 62,407,000 | 3.24% | ||
| 9 | NEVRO CORP | 660,428 | 48,713,000 | 2.53% | ||
| 10 | LOXO ONCOLOGY INC COM | 1,792,207 | 41,543,000 | 2.16% | ||
| 11 | CARE COM INC COM | 3,260,989 | 38,088,000 | 1.98% | ||
| 12 | PROTEOSTASIS THERAPEUTICS IN | 3,095,240 | 37,545,000 | 1.95% | ||
| 13 | LEXICON PHARMACEUTICALS | 2,382,286 | 34,186,000 | 1.77% | ||
| 14 | ENDOLOGIX INC | 2,490,204 | 31,028,000 | 1.61% | ||
| 15 | AEROHIVE NETWORKS INC | 4,681,455 | 30,991,000 | 1.61% | ||
| 16 | TREVENA INC | 3,811,691 | 24,014,000 | 1.25% | ||
| 17 | ACHAOGEN INC COM | 4,715,128 | 17,870,000 | 0.93% | ||
| 18 | EXELIXIS INC | 2,207,000 | 17,237,000 | 0.89% | ||
| 19 | CLOVIS ONCOLOGY INC | 1,139,890 | 15,639,000 | 0.81% | ||
| 20 | MIRNA THERAPEUTICS INC | 2,974,811 | 12,673,000 | 0.66% | ||
| 21 | CASCADIAN THERAPEUTICS INC | 10,750,000 | 10,105,000 | 0.52% | ||
| 22 | AVEO PHARMACEUTICALS INC | 10,362,694 | 9,948,000 | 0.52% | ||
| 23 | Strongbridge Biopharma plc | 2,141,308 | 8,522,000 | 0.44% | ||
| 24 | Tracon Pharmaceuticals Inc | 1,889,652 | 8,277,000 | 0.43% | ||
| 25 | RIGEL PHARMACEUTICAL INC | 3,243,150 | 7,232,000 | 0.38% | ||
| 26 | AURINIA PHARMACEUTICALS INC | 2,546,843 | 7,055,000 | 0.37% | ||
| 27 | AKARI THERAPEUTICS PLC | 452,167 | 6,100,000 | 0.32% | ||
| 28 | ZHONE TECHNOLOGIES INC NEW | 4,781,290 | 5,690,000 | 0.30% | ||
| 29 | ArQule Inc | 2,520,316 | 4,789,000 | 0.25% | ||
| 30 | Sunesis Pharmaceuticals I | 7,789,644 | 4,284,000 | 0.22% | ||
| 31 | ARCA BIOPHARMA INCORPORATED COM PAR .001 | 1,460,209 | 4,235,000 | 0.22% | ||
| 32 | CHAMPIONS ONCOLOGY INC | 1,562,500 | 3,359,000 | 0.17% | ||
| 33 | Zosano Pharma Corp | 2,158,543 | 2,741,000 | 0.14% | ||
| 34 | ROKA BIOSCIENCE INC | 3,220,433 | 1,836,000 | 0.10% | ||
| 35 | Orexigen Therapeutics, Inc. | 370,900 | 1,595,000 | 0.08% | ||
| 36 | Cerecor Inc | 595,435 | 1,310,000 | 0.07% | ||
| 37 | Agile Therapeutics, Inc. | 133,488 | 1,016,000 | 0.05% | ||
| 38 | Catalyst Biosciences | 652,380 | 992,000 | 0.05% | ||
| 39 | PARATEK PHARMACEUTICALS INC | 66,245 | 921,000 | 0.05% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001512848-16-000008, filed 2016.08.05).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
